InterVenn Biosciences

InterVenn Biosciences

InterVenn Biosciences

InterVenn Biosciences combines AI/ML, glycoproteomics & LCMS for biomarker and target discovery.
Type
B2c
Founded
2017
Raised
$34M
Follow us
Alexa global traffic share
Latest funding
$34,000,000
Venture capital (Series B) - 2020
Amplify Partners True Ventures Xeraya Capital +3
Team Size
1–10
Employees
$34,000,000 Venture capital (Series B)
e27: Asia tech news , DealStreetAsia

Malaysian VC Xeraya Capital joins US biotech firm InterVenn's US$34M round | e27